ViroPharma, Inc. (NASDAQ:VPHM)

CAPS Rating: 4 out of 5

A biopharmaceutical company dedicated to the development and commercialization of products that address serious infectious diseases, with a focus on products used by physician specialists or in hospital settings.

Recs

0
Player Avatar onzelot (< 20) Submitted: 10/27/2010 4:06:23 PM : Outperform Start Price: $16.72 VPHM Score: +9.38

Brings their the product to the rest of the world

Featured Broker Partners


Advertisement